ADPTAdaptive Biotechnologies Corpvs its industry peers
A metric-by-metric comparison of Adaptive Biotechnologies Corp against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADPTEsta | $4.3B#4 | — | 24.6x#4 | 15.7x#2 | 54.8%#3 | 62.7%#2 | -20.6%#1 | -33.8%#2 | — | — | 52.4%#3 | — |
| IBRX | $8.5B#1 | — | — | 74.9x#4 | 668.3%#1 | 15.0%#3 | -226.0%#4 | — | — | — | — | — |
| TWST | $7.6B#2 | — | 17.0x#2 | 20.1x#3 | 20.3%#4 | 62.8%#1 | -36.2%#2 | -17.4%#1 | -41.4%#1 | — | 282.4%#1 | — |
| SRRK | $5.5B#3 | — | 21.8x#3 | — | — | -53.7%#5 | — | -148.9%#4 | -2854.7%#2 | — | 62.7%#2 | — |
| IOVA | $3.6B#5 | — | 4.4x#1 | 13.5x#1 | 60.6%#2 | -5.1%#4 | -153.1%#3 | -48.1%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice